NCOA3 and breast carcinoma: As a result, SI-2 selectively suppresses the proliferation of breast cancer cells at concentrations in the low nanomolar range (IC50 of 3–20 nM) but does not substantially affect the viability of normal cells due to the exceptional dependence of cancer cells on SRC-3 [11].